Semaglutide, the active ingredient in Ozempic, and other drugs in the same class have revolutionized the treatment of obesity and type 2 diabetes. Now, a clinical trial suggests the medicines can ...

CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a randomized trial showed. In this 26-week, double-blind trial of 72 adults, 36% ...

The medication labels for Ozempic and Mounjaro, which are prescribed to help people with type 2 diabetes manage blood sugar, specifically say they are not intended for use with type 1. However ...

More information: Viral N. Shah et al, Semaglutide in Adults with Type 1 Diabetes and Obesity, NEJM Evidence (2025). DOI: 10.1056/EVIDoa2500173 ...

A new stem cell treatment could eliminate the need for insulin therapy in people with type 1 diabetes, a disease where the ...

A new study finds the use of weight loss drugs like Ozempic, Wegovy, and Zepbound in people with Type-1 Diabetes has risen sharply. It comes even though there's little information on the drugs ...

More people with type 1 diabetes are using GLP-1s like Ozempic and Zepbound, a new study found. Researchers attribute the high demand to rising rates of obesity among people with type 1 diabetes.

A new experimental treatment may be able to cure type 1 diabetes. About 83% of the patients were able to stop using insulin after the treatment. Research into the treatment is ongoing.

Sold under the trade names such as Ozempic, Wegovy and Rybelsus, the drug was initially developed for the treatment of Type 2 diabetes, helping to manage blood sugar levels.

GLP-1 agonists, including liraglutide, are typically used to control blood sugar levels in type 2 diabetes and to promote weight loss. These drugs mimic a hormone released after eating, helping to ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related cancers, especially colorectal cancer, according to data released on ...

Here’s how it works. GLP-1 agonists, the class of drug that includes Ozempic, may be useful for managing type 1 diabetes. (Image credit: Tatsiana Volkava via Getty Images) ...